Filing Flows

Filing Flows › Everforth (EFOR) › Q3 2026 › vs Q2 2026

Everforth (EFOR) Q3 2026 vs Q2 2026 (quarter over quarter)

Everforth's revenue rose $24.4M (+2%) from $1.0B in Q2 2026 to $1.0B in Q3 2026. The biggest changes: Commercial +$18.2M (+3%); Federal Government +$6.2M (+2%). Gross margin 28.3% against 28.3% (+0.0 pts).

Everforth, Q3 2026: revenue $1.0B (+2% year over year), operating margin 5.5%, net earnings $23.1M, operating cash flow $58.7M. The chart draws each line against Q2 2026, the increases inside each band.

Everforth: what changed, Q3 2026 vs Q2 2026Everforth: what changed, Q3 2026 vs Q2 2026Commercial$18.2MCost of revenue$17.4MPre-tax earnings$15.7MOperating profit$15.5MNet earnings$8.9MOperating expenses−$8.5MSG&A−$8.5MGross profit$7.0MIncome tax$6.8MOperating cash flow$6.5M

Margins

Q3 2026Q2 2026Change
Gross margin28.3%28.3%+0.0 pts
Operating margin5.5%4.1%+1.4 pts
Net margin2.2%1.4%+0.8 pts
Free cash flow margin4.5%4.6%-0.1 pts

Every line

LineQ3 2026Q2 2026Change%
Commercial$720M$702M$18.2M+3%
Federal Government$312M$305M$6.2M+2%
Revenue$1.0B$1.0B$24.4M+2%
Gross profit$292M$285M$7.0M+2%
Cost of revenue$740M$722M$17.4M+2%
Operating profit$56.6M$41.1M$15.5M+38%
Operating expenses$235M$244M−$8.5M-3%
Pre-tax earnings$36.4M$20.7M$15.7M+76%
Other expense, net$20.2M$20.4M−$200K-1%
SG&A$218M$226M−$8.5M-4%
Other operating costs$17.3M$17.3M$00%
Net earnings$23.1M$14.2M$8.9M+63%
Income tax$13.3M$6.5M$6.8M+105%
Depreciation & amortization$28.9M$31.2M−$2.3M-7%
Share-based compensation$12.5M$14.6M−$2.1M-14%
Working capital & other$5.8M$7.8M−$2.0M-26%
Operating cash flow$58.7M$52.2M$6.5M+12%
Free cash flow (OCF − capex)$46.5M$46.3M$200K+0.4%
Capital expenditures$12.2M$5.9M$6.3M+107%

Questions

How much did Everforth's revenue grow quarter over quarter in Q3 2026?

Everforth's revenue rose $24.4M (+2%) from $1.0B in Q2 2026 to $1.0B in Q3 2026.

What drove Everforth's revenue change in Q3 2026?

Commercial +$18.2M (+3%); Federal Government +$6.2M (+2%).

Q3 2026 results → · Compare in the interactive Sankey →